Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

By K. Jamerson, M. Weber, G. Bakris, B. Dahlöf, B. Pitt, V. Shi, A. Hester, Jitendra Gupte, M. Gatlin, E. Velazquez. New England Journal of Medicine, 2008

1,807 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/51b74619a09b36d0e31c50ef230dab95e05c53df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Endocrinology, Diabetes and Metabolism

Citations in the corpus

ESH / ESC Guidelines for the management of arterial hypertension (2013, methodology): “the large number of RCTs of antihypertensive therapy, only three systematically used a given two-drug combination in at least one arm: the ADVANCE trial compared an ACE inhibitor and diuretic combination with placebo (but on top of continued background therapy),(276) FEVER compared a calcium antagon”
2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, positive): “[451] Despite the trial evidence of outcome reduction, the β-”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, methodology): “Among the large number of RCTs of antihypertensive therapy, only three systematically used a given two-drug combination in at least one arm: the ADVANCE trial compared an ACE inhibitor and diuretic combination with placebo (but on top of continued background therapy) [276], FEVER compared a calcium ”
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, methodology): “Among the large number of RCTs of antihypertensive therapy, only three systematically used a given two-drug combination in at least one arm: the ADVANCE trial compared an ACE inhibitor and diuretic combination with placebo (but on top of continued background therapy) [276], FEVER compared a calcium ”
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. (2016, background): “Because ACEIs and ARBs can slow progression of nephropathy and retinopathy, they are preferred for patients with T2D (162,166-168).”
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, positive): “Trial evidence of outcome reduction has been obtained particularly for the combination of a diuretic with an ACE inhibitor or an angiotensin receptor antagonist or calcium antagonist.(429,430)”
2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, methodology): “Trial evidence of outcome reduction has been obtained, particularly for the combination of a diuretic with an ACE-I, an ARB or a calcium antagonist.(451) Despite the trial evidence of outcome reduction, the b-blocker/ diuretic combination favours the development of DM and should”